Importantly however, our results indicate that harnessing the mechanisms of amplifying glucagon signaling through the hepatic cAMP-PKA-CREB signaling nexus is a viable option with a plethora of potential for developing therapies for HI associated hypoglycemia. This evidence concerns the gene GCG and Hypoglycemia.